Search research articles
Contact Us
Filters
Showing results (201-210 of 233) with videos related to
Page
of 24
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 18, 2013
Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa
Raphael Schiffmann, Markus Ries, Derek Blankenship, et al.
Laryngo- Rhino- Otologie
|
July 23, 2021
[Therapies for synchronous malignomas - the importance of interdisciplinary oncology]
Sarina Müller, Marlen Haderlein, Maximilian Traxdorf, et al.
Molecular and Cellular Biochemistry
|
April 22, 2022
Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis
Rebekka Pohl, Laura Eichelberger, Susanne Feder, et al.
Orphanet Journal of Rare Diseases
|
June 20, 2022
Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry
Michael Beck, Uma Ramaswami, Elizabeth Hernberg-Ståhl, et al.
The Journal of Pediatrics
|
May 6, 2004
Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)
James E Wraith, Lorne A Clarke, Michael Beck, et al.
Orphanet Journal of Rare Diseases
|
May 4, 2017
Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry
Joseph Muenzer, Simon A Jones, Anna Tylki-Szymańska, et al.
American Journal of Medical Genetics. Part A
|
February 4, 2005
Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
Stuart J Swiedler, Michael Beck, Manal Bajbouj, et al.
Orphanet Journal of Rare Diseases
|
September 28, 2013
Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease
Yildiz Yildiz, Per Hoffmann, Stefan Vom Dahl, et al.
Contact Dermatitis
|
August 8, 2007
Dicaprylyl maleate--an emerging cosmetic allergen
Helen Lotery, Stephen Kirk, Michael Beck, et al.
Molecular Genetics and Metabolism
|
December 3, 2009
A validated disease severity scoring system for Fabry disease
Edward H Giannini, Atul B Mehta, Max J Hilz, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 233) with videos related to
Sort By:
Page
of 24
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 18, 2013
Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa
Raphael Schiffmann, Markus Ries, Derek Blankenship, et al.
Laryngo- Rhino- Otologie
|
July 23, 2021
[Therapies for synchronous malignomas - the importance of interdisciplinary oncology]
Sarina Müller, Marlen Haderlein, Maximilian Traxdorf, et al.
Molecular and Cellular Biochemistry
|
April 22, 2022
Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis
Rebekka Pohl, Laura Eichelberger, Susanne Feder, et al.
Orphanet Journal of Rare Diseases
|
June 20, 2022
Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry
Michael Beck, Uma Ramaswami, Elizabeth Hernberg-Ståhl, et al.
The Journal of Pediatrics
|
May 6, 2004
Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)
James E Wraith, Lorne A Clarke, Michael Beck, et al.
Orphanet Journal of Rare Diseases
|
May 4, 2017
Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry
Joseph Muenzer, Simon A Jones, Anna Tylki-Szymańska, et al.
American Journal of Medical Genetics. Part A
|
February 4, 2005
Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
Stuart J Swiedler, Michael Beck, Manal Bajbouj, et al.
Orphanet Journal of Rare Diseases
|
September 28, 2013
Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease
Yildiz Yildiz, Per Hoffmann, Stefan Vom Dahl, et al.
Contact Dermatitis
|
August 8, 2007
Dicaprylyl maleate--an emerging cosmetic allergen
Helen Lotery, Stephen Kirk, Michael Beck, et al.
Molecular Genetics and Metabolism
|
December 3, 2009
A validated disease severity scoring system for Fabry disease
Edward H Giannini, Atul B Mehta, Max J Hilz, et al.
Page
of 24